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INTRODUCTION

METHODS & RESULTS
Figure 2: Extraction Procedure

Plants naturally produce a robust supply of novel
metabolic compounds that can be used to treat a variety of
human diseases. From 1981 to 2010, it is estimated that
nearly 50% of all cancer drugs originated from natural
products [1], many of which were derived from terrestrial
plants [2]. Likewise, plants produce many antimicrobial
agents, which include a wide variety of natural defense
compounds, such as phenolics, terpenoids, alkaloids,
polyacetylenes, lectins and polypeptides [3].
With the advent of modern antibiotic drugs mainly of
bacterial, fungal and synthetic sources, many of these
natural plant-derived antibiotic compounds have been left
unexplored. Yet with the high number of antibiotic-resistant
pathogenic microorganisms, there is a pressing need for
the development of new classes of antibiotic drugs (Fig. 1).

Extract Preparation. Whole Argemone mexicana plants
were separated into leaves, seeds, inner or outer roots and
allowed to dry in paper bags at 22oC. 2 grams of each dried
sample was homogenized using a mortar and pestle. The
powdered sample was then macerated in methanol or
hexane using a 1:4 (plant material:solvent) ratio at 200 rpm,
35oC for 48 hours. The mixture was centrifuged at 5,000 x g
for 5 minutes, and the supernatant was filtered through a 0.2
uM PTFE membrane. The filtrate was then dehydrated,
quantified and tested for biological activity.

Figure 3: Antimicrobial & Anticancer Experiments
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Figure 1. Timeline of antibiotic deployment and
the evolution of antibiotic resistance (taken from [4]).
One promising medicinal plant candidate is the fairly
unexplored Argemone mexicana, commonly called the
Mexican prickly poppy. A. mexicana is a stress-resistant
member of the Papaveraceae family of plants that has
been used since the time of the Aztecs [5] to treat a wide
variety of ailments, such as: tumors, warts, skin diseases,
inflammation, rheumatism, jaundice, leprosy, microbial
infections, and malaria [6]. Some chemical and
pharmacological aspects of A. mexicana have been
identified [6], but, until the publication of this research [7],
very few bioactive compounds had been identified in the
plant to account for its many medicinal effects. Thus, this
plant possesses great potential for the discovery of novel
antibiotic and anticancer compounds, which is the nature
of the work herein.
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A. Antimicrobial Disc Diffusion Assay. Blank antibiotic
sensitivity discs were impregnated with 1 mg of A. mexicana
extract from the leaf, seed, inner or outer root. Discs were then
placed onto a media plate with a lawn of the appropriate
microorganism. After 48 h of growth, zones of inhibition were
measured. The average zone of inhibition in millimeters for five
biological replicates is shown with associated SEM.
B. Cancer Cell Viability Assay. T84 human colon cancer cells
were treated with 1 mg of leaf, seed, inner root or outer root
extract for 1 h. The MTT colorimetric assay was then used to
determine cell metabolic activity after treatment with extracts. The
mean percentage of viable cells normalized to the control (solvent
alone) for at least three biological replicates is shown with SEM.

Figure 4: Chemical Characterization

CONCLUSIONS &
ON-GOING WORK
• Outer root methanol extracts possess
antimicrobial activity, with greatest effects
against gram-positive bacteria (Fig. 3).
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• Outer root methanol and seed hexane
extracts have inhibitory effects against
T84 human colon cancer cells (Fig. 3).

Chemical Characterization of Root and Leaf
Methanol extracts. Column chromatography, highresolution mass spectroscopy and nuclear magnetic
resonance were performed to separate and identify
antimicrobial phytocompounds from A. mexicana
root and leaves. Chelerythrine was consistent with
root fraction ‘D’, while berberine was consistent with
root fraction ‘E’ and with leaf fraction ‘10.5’.

•

mRNA levels of c-MYC (oncogene) and
APC (tumor suppressor) were quantified:

•

Chelerythrine and berberine were found
as main antibiotic compounds in the roots
and/or leaves of A. mexicana (Fig. 4).

•

Recent work on synthesizing and testing
new berberine and chelerythrine variants
can be found at posters #38 and #68.
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